Presentation (CTI)

OBJECTIVES: The objective of this primary research study is to investigate U.S. payer perspectives, preferences, and utilization of Academy of Managed Care Pharmacy (AMCP) dossiers to support formulary and coverage decision-making, one year after the release of Version 5.0 of the AMCP Format for Formulary Submissions.
METHODS: Experienced stakeholders from U.S. payer organizations will be recruited (n=15 to 20) to participate in an online quantitative and qualitative primary research survey in early 2025. Within the survey, we will explore key themes related to AMCP pre-approval and approved product dossiers. Results will be aggregated, and reported using descriptive statistics and contextual analyses, with key findings highlighted.
RESULTS: The survey sample will include a diverse range of payer stakeholders, including medical directors, pharmacy directors, and industry/trade relations professionals, representing national and regional managed care organizations (MCOs), pharmacy benefit managers (PBMs), and integrated delivery networks (IDNs). Results will be reported around key survey themes including dossier timing and availability relative to the product lifecycle, evidence priorities and preferences, and commonly observed shortcomings. Additionally, results will include payer perspectives on the updated guidance included in Format Version 5.0.
CONCLUSIONS: As engagement between manufacturers and healthcare decision-makers in the U.S. continues to evolve, it is critical to understand payer perspectives on best practice for the development and dissemination of AMCP dossiers, as well as the role of dossiers in facilitating timely product assessment and reimbursement.